S
Scorpius BioManufacturing is a CDMO with integrated solutions for large molecule cGMP manufacturing, process and analytical method development, product characterization, and release testing needs. Scorpius' facility in San Antonio, TX has capacity for both mammalian and microbial clinical manufacturing projects.
Investor insights
Funding rounds participated in
$1.5M sweet spot round size
Investor type
Public Company
Basic info
Industry
Pharmaceutical Manufacturing
Sectors
Pharmaceutical Manufacturing
Date founded
2020
Funding rounds raised
Total raised
$1.5M
from investors over 1 rounds
S
Scorpius BioManufacturing, Inc. raised $1.5M on April 8, 2024